WO2000047247A1 - Technique d'utilisation detournee d'un dispositif dans un but de prevention du cancer canalaire du sein - Google Patents
Technique d'utilisation detournee d'un dispositif dans un but de prevention du cancer canalaire du sein Download PDFInfo
- Publication number
- WO2000047247A1 WO2000047247A1 PCT/US2000/003661 US0003661W WO0047247A1 WO 2000047247 A1 WO2000047247 A1 WO 2000047247A1 US 0003661 W US0003661 W US 0003661W WO 0047247 A1 WO0047247 A1 WO 0047247A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wall
- mammary
- mammary gland
- breast pad
- breast
- Prior art date
Links
- 210000000481 breast Anatomy 0.000 title claims description 58
- 238000000034 method Methods 0.000 title description 18
- 206010028980 Neoplasm Diseases 0.000 title description 4
- 201000011510 cancer Diseases 0.000 title description 4
- 210000005075 mammary gland Anatomy 0.000 claims abstract description 63
- 239000003599 detergent Substances 0.000 claims abstract description 18
- 235000002566 Capsicum Nutrition 0.000 claims abstract description 3
- 240000008574 Capsicum frutescens Species 0.000 claims abstract description 3
- 239000001390 capsicum minimum Substances 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims description 11
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 5
- 238000004891 communication Methods 0.000 claims description 3
- 229940124549 vasodilator Drugs 0.000 claims description 2
- 239000003071 vasodilator agent Substances 0.000 claims description 2
- 239000000243 solution Substances 0.000 claims 5
- 239000007864 aqueous solution Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 150000002978 peroxides Chemical class 0.000 claims 1
- 229920001296 polysiloxane Polymers 0.000 claims 1
- 239000000344 soap Substances 0.000 claims 1
- 102000011782 Keratins Human genes 0.000 abstract description 10
- 108010076876 Keratins Proteins 0.000 abstract description 10
- 238000007789 sealing Methods 0.000 abstract 1
- 239000012530 fluid Substances 0.000 description 43
- 210000002445 nipple Anatomy 0.000 description 12
- 102000003946 Prolactin Human genes 0.000 description 8
- 108010057464 Prolactin Proteins 0.000 description 8
- 229940097325 prolactin Drugs 0.000 description 8
- 206010006187 Breast cancer Diseases 0.000 description 7
- 208000026310 Breast neoplasm Diseases 0.000 description 7
- 229940088597 hormone Drugs 0.000 description 7
- 239000005556 hormone Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 6
- 230000036541 health Effects 0.000 description 5
- 230000007306 turnover Effects 0.000 description 5
- 238000007906 compression Methods 0.000 description 4
- 230000006835 compression Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- 230000006651 lactation Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 238000013461 design Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 210000004251 human milk Anatomy 0.000 description 3
- 235000020256 human milk Nutrition 0.000 description 3
- -1 polypropylene Polymers 0.000 description 3
- 230000001850 reproductive effect Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 2
- XNOPRXBHLZRZKH-UHFFFAOYSA-N Oxytocin Natural products N1C(=O)C(N)CSSCC(C(=O)N2C(CCC2)C(=O)NC(CC(C)C)C(=O)NCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(CCC(N)=O)NC(=O)C(C(C)CC)NC(=O)C1CC1=CC=C(O)C=C1 XNOPRXBHLZRZKH-UHFFFAOYSA-N 0.000 description 2
- 101800000989 Oxytocin Proteins 0.000 description 2
- 102100031951 Oxytocin-neurophysin 1 Human genes 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000003181 biological factor Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- XNOPRXBHLZRZKH-DSZYJQQASA-N oxytocin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@H](N)C(=O)N1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 XNOPRXBHLZRZKH-DSZYJQQASA-N 0.000 description 2
- 229960001723 oxytocin Drugs 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 229920001169 thermoplastic Polymers 0.000 description 2
- 239000004416 thermosoftening plastic Substances 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 206010050337 Cerumen impaction Diseases 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 206010062767 Hypophysitis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000002870 angiogenesis inducing agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002939 cerumen Anatomy 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 231100000590 oncogenic Toxicity 0.000 description 1
- 230000002246 oncogenic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/06—Milking pumps
- A61M1/062—Pump accessories
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/06—Milking pumps
- A61M1/062—Pump accessories
- A61M1/064—Suction cups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/06—Milking pumps
- A61M1/062—Pump accessories
- A61M1/064—Suction cups
- A61M1/066—Inserts therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/06—Milking pumps
- A61M1/069—Means for improving milking yield
- A61M1/0697—Means for improving milking yield having means for massaging the breast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/36—General characteristics of the apparatus related to heating or cooling
- A61M2205/366—General characteristics of the apparatus related to heating or cooling by liquid heat exchangers
Definitions
- the present invention generally relates to breast pumps but more particularly to breast pump technology designed to obtain breast fluids from non-lactating breasts while stimulating elevated levels of prolactin in the blood.
- Breast cancer is one of the leading causes of disease and death in women, with greater than 90% of breast cancer originating in the epithelial cells of the ducts of the breast.
- Early detection and treatment of breast cancer has focused on improving prognosis and increasing the survival rates. Renewed focus on prevention and detection of breast cancer has lead to the use of numerous biological indicators in mammary fluid and methods of early detection of breast cancer risk.
- Such indicators include numerous oncogenic determinants, cytokines, angiogenic factors, proteins and nucleic acids, as well as biochemical products and lipids.
- breast pumps have been used to remove milk from a lactating mother's breasts. These breast pumps include both powered and manual versions.
- a breast pump applies suction to the breast tissue with the intended result being the flow and capture of a quantity of milk for use in feeding a baby.
- the shape of the breast funnel and performance of the suction unit vary in different models, some being more efficient in pumping than others due to the differences in design and individual breast physiology.
- the pumps designed for obtaining mammary fluid from lactating subjects do not generally draw fluids from non-lactating subject.
- a more routine method of obtaining ductal fluid has been the performance of fine needle aspiration methods, as described in U.S. Patent No. 4,697,600 issued to Cardenas et al. on October 6, 1987. Because the needle asporation methods aare painful, women are understandably reluctant to consent to those processes to obtain a ductal fluid sample from their breasts unless they have already been diagnosed with breast cancer or believe to be at very high risk for the disease.
- breast ductal fluid content can be altered to improve health by systematically removing the existing fluid from the ducts on a regular basis, thus increasing fluid turnover in the breast.
- Such fluid turnover is thought to increase blood flow, hormones, and biological factors which are effective in reducing the risk of breast cancer. Examples of biological factors include carotenoids.
- the invention provides compositions, systems and devices useful in obtaining fluid from the mammary gland of a female subject.
- the subject can be any mammal including humans.
- the female will typically be a non-lactating female.
- the methods systems and devices are useful in removing keratin plugs found in the ducts of the mammary gland and in obtaining fluids from the mammary gland by warming and providing compression or vibration stimuli to the mammary gland.
- a mammary gland pad is provided containing a detergent solution or a detergent solution combined with other active ingredients, which is useful in removing keratin plugs from the ductal glands of mammary tissue. This pad can be used alone or in combination with the mammary funnel system of the invention.
- a mammary funnel system which is capable of heating the mammary gland to increase blood flow and reduce viscosity of the mammary fluid.
- the mammary funnel system is capable of providing additional compression stimuli to the mammary gland to further promote fluid secretion.
- the mammary funnel system is further capable of providing vibrational stimulation to promote expression of viscous mammary fluid from the breast.
- the system, methods and devices of the invention are useful in promoting expression of mammary gland fluids, thereby increasing fluid turnover, reducing accumulation of carcinogenic agents in the breast tissue fluid, stimulating the rise of hormonal levels associated with lactation, and increasing the presence of beneficial biological agents in the mammary gland fluids.
- FIG. 1 is a depiction of the mammary funnel system of the invention having a substantially rigid tubular portion 15 and a pliable tubular structure 40 in contact with a mammary gland 12.
- FIG. 2 shows the substantially rigid tubular portion 15 in further detail including the stimuli elements 30 and 35, sampling opening 32, and connector regions 60, 65, and 70.
- FIG. 3 shows the pliable tubular structure 40 in more detail, including openings 45 and 50 and regions of varying thickness 55.
- FIG. 4 shows the mammary funnel 10 in use with a mammary gland 12.
- A. shows the funnel as it is being pressed against the mammary gland.
- the substantially rigid portion 15 provides resilience as the funnel is pressed against the mammary gland.
- B. shows the mammary funnel 10 in use with the mammary gland.
- a vacuum 65 causes the regions of varying thickness 55 to collapse and exert pressure on the nipple of the mammary gland 12. Fluid is expressed 34, which can be collected through sampling opening 32.
- FIG. 5 A shows a mammary gland pad 80.
- FIG. 5B shows a mammary gland pad 80 in contact with a mammary gland 12.
- prolactin plays a significant role in the integrity and health of the epithelial lining of the breast duct system and the digestive system.
- prolactin triggers the production of breast milk.
- Prolactin levels are elevated during suckling and, depending upon the frequency of the suckling activity, can either reach lactation levels or remain elevated but below the level needed to trigger lactation.
- Research indicates that elevated blood serum prolactin levels are consistent with positive changes in the epithelial lining of the breast duct and intestines, possibly rendering them more resistant to disease such as cancer and infection.
- the ability to manipulate hormone levels though a pre-defined process of nipple stimulation using the devices of the invention may prove to be a useful intervention in breast ductal cancer, and other hormone related diseases.
- the nipples of the breast serve as somewhat of a "control panel" to the pituitary gland where prolactin, oxytocin and other hormones are manufactured. Since oxytocin and prolactin are both reproductive hormones, the presence of these hormones in high levels indicates the individual's membership in the reproductive population. There is some rationale for health related defensive mechanism that would protect the members of the reproductive population from illness or death in order to increase the chance of survival for offspring.
- the keratin plugs effectively seal the breast contents behind them, making it difficult or impossible for the breast to drain naturally as well as impossible to remove ductal fluid using suction only.
- the keratin plugs are comprised of basically the same material as earwax, with the same tendency to harden into a solid plug.
- the ductal fluid is typically thick in non-lactating females. It moves very slowly through the duct to the nipple, further necessitating a system that differs greatly in design from conventional breast milk pumps. Because of the thickness of the fluid and its inability to form a stream, it becomes necessary to capture the fluid in something other than a container.
- the methods, systems, and devices envisioned by the inventor include multiple steps or device elements. In some females, not all steps in the process are necessary to achieve the desired results of cleansing the ducts, obtaining ductal fluid and/or elevating prolactin. The inventor believes that the process may be effective on some individuals without utilizing all steps or all elements present in the devices of the invention.
- the mammary gland funnel of the invention is applicable to all mammalian females, including for example, humans, exotic mammals, such as rhinos and tigers, as well as to domestic animals including cattle, cats, and dogs.
- the mammary gland funnel of the invention provides heat, compression stimuli, and suction simultaneously to the breast. In one embodiment, a further stimuli of vibration is added to assist in obtaining breast ductal fluids.
- the invention provides a mammary gland funnel system (10) for obtaining breast ductal fluid from the mammary gland (12) of non-lactating females.
- the pump has a number of features that overcome the deficiencies of the standard breast pump systems used for lactating females.
- FIG. 1 shows one embodiment of the invention.
- the pump has a substantially-rigid tubular structure (15) having a first opening (20) and a second opening (25).
- the substantially-rigid tubular structure has at least one stimuli element (30 or 35) for delivering a stimulus to mammary gland (12).
- One or more connector ports (60, 65, or 70) are present at the second end of the substantially-rigid tubular structure.
- a pliable tubular structure (40) Nested within the substantially-rigid tubular structure (15) is a pliable tubular structure (40) having a first end (45) and a second end (50).
- the pliable tubular structure (40) has areas of varying thickness (55) in the structure.
- the pliable tubular structure (40) is attached at its first end (45) and its second end (25) to the wall (18) of the substantially-rigid tubular structure (15) to form a seal (e.g., a vacuum seal).
- FIG. 2 shows the substantially-rigid tubular structure (15) in more detail.
- the substantially-rigid tubular structure (15) has at least one wall (18) defining a first opening (20) and a second opening (25).
- the substantially-rigid tubular structure has at least one stimuli element (30 or 35) coupled to the tubular structure (15) for delivering a stimulus to mammary gland (12).
- One or more connector ports (60, 65, or 70) are present proximate the second opening of the substantially-rigid tubular structure (15).
- substantially-rigid is meant that the material from which the structure is made is resistant to collapsing under pressure, such materials include, for example, polypropylene, polystyrene and others known to those of skill in the art or easily identified by those of skill in the art.
- the substantially-rigid tubular structure (15) is tapered somewhat like a funnel, where the first opening (20) is broader and receives the mammary gland (12).
- the second opening (25) may have at least one connector for connection to a vacuum (65), and connectors (60 or 70) for connection to stimuli element leads.
- Stimuli elements (30 or 35) include for example, heating elements (30) and vibrating elements (35).
- Such elements are useful in providing stimulus to the mammary gland of the female during the process of obtaining breast fluid.
- the design of such elements include inner pouches molded in the funnel material filled with a liquid that is able to hold a heated temperature for a given period of time. In such instances the funnel can be warmed by preparation in a microwave oven, conventional oven, warm water bath, boiling water, solar power or other methods known in the art.
- small heat elements may be coupled to the funnel or clipped on to the funnel.
- Such elements include those used in heating blankets and similar devices.
- the stimuli elements (30 or 35) can be coupled to the wall of the tubular structure (15) in any number of ways. For example, the elements (30 or 35) can be attached to the surface of the wall (18), embedded in the wall (18) or integrally formed within the wall (18) of the tubular structure (15).
- FIG. 3 shows the pliable tubular structure (40) in more detail.
- the pliable tubular structure has at least one wall (42) defining a first end (45) and a second end (50).
- the wall (42) of the tubular structure (40) is capable of collapsing under pressure (e.g., vacuum pressure).
- the tubular structure (40) typically will be larger at one end and tapered to the opposite end more or less in the shape of a funnel.
- the wall (42) has a plurality of regions of varying thickness (55). These regions of varying thickness (55) are typically integral with the wall (42).
- the regions of varying thickness (55) can be formed in any number of ways and include varying the thickness of the polymer material from which the wall (42) is made, by providing liquid filled regions within the wall (42), or by providing air filled regions within the wall (42). Other methods for creating regions of varying thickness (55) will be recognized by those of skill in the art.
- the regions of varying thickness (55) are designed to collapse at a different pressure than the remainder of the wall (42). By varying the degree of collapse the degree of compression on the mammary gland can be modulated.
- the second end (50) can be designed to be in vacuum communication with vacuum source, such as, for example, a hand held pump or portable pump or a wall vacuum with a regulator.
- FIG. 4 diagrammatically shows the mammary gland funnel system (10) in use.
- the funnel system (10) is aligned with the nipple and mammary gland (12) and is forcibly pressed inwardly towards the mammary gland (12) sufficient to cause the nipple to be inserted into the opening (45) of the pliable tubular structure (40).
- the substantially-rigid tubular structure (15) provides sufficient resilience to prevent collapse under the pressure of forcing the funnel onto the mammary gland.
- the pliable tubular structure (40) receives the nipple of the mammary gland (12) through opening (45).
- the stimuli elements (30 or 35) may be activated prior to contact with the mammary gland (e.g., the funnel system (10) may be pre-warmed by a heating element (30)) or may be warmed after the funnel system (10) is contacted with the mammary gland (12).
- the mammary gland e.g., the funnel system (10) may be pre-warmed by a heating element (30)
- a heating element (30) may be warmed after the funnel system (10) is contacted with the mammary gland (12).
- the ductal fluids (34) can be sampled through sampling port (32) using a capillary pipette, filter paper or other devices useful in obtaining or measuring a biological fluid sample.
- the invention provides a mammary gland pad useful in removing keratin plugs present in the ducts of the mammary gland.
- the pad can be of any shape, but typically will be of a shape that fits comfortably over the breast of a female. For example, where the female is human, the pad can be designed to fit within the brassier.
- the pad has disposed within it a detergent solution, which may include other active ingredients (e.g., capsicum or other vasodilators), useful in removing keratin plugs and dilating nipple ducts.
- a typical solution ratio will be about 1/8 teaspoon of baking soda per 1/2 cup of water.
- Other detergent solutions will be readily identifiable in the art (e.g., liquid detergents such as IVORY).
- the solution can be disposed in a pocket of the pad (as described more fully below) or integral to one or more layers of the pad.
- the pad will typically be applied to the mammary gland, particularly the nipple of the mammary gland for about 10 minutes to 24 hours or for a sufficient time to assist in dissolving or removal of keratin plugs.
- FIG. 5 is a diagram showing the mammary gland pad of the invention.
- FIG 5 A shows a typical pad (80) comprising at least two walls. A first wall (100) and a second wall (200) are fixedly connected. The walls can be connected at their periphery or throughout the area of each wall. Where walls (100 and 200) are connected only at the periphery a pocket or pouch (230) is formed between the two walls. This pouch or pocket can be used to hold a detergent solution useful to remove keratin plugs. Alternatively, a detergent based solution can be integrally applied to the fibers or composite material (250) of at least one wall (200).
- FIG. 5B shows the pad of the present invention during use.
- Wall (200) is in contact with the mammary gland (12).
- Wall (200) will typically contain or be permeable to liquids, and in particular permeable to a detergent solution, present within the pad.
- Wall (100) may be impermeable to liquids to avoid staining or wetting of clothing or garments that may be in contact with the pad (80).
- the walls of the pad (80) can be formed of any number of materials.
- wall (100) will typically be formed of a thin thermoplastic film, such as polyethylene film, which is substantially impermeable to liquid. This functions to prevent the detergent solution contained in the pad from wetting or soiling the wearer's clothing, bedding, or other materials contacting pad.
- the wall may be, for example, a polyethylene film having an initial thickness of from about 0.5 mil (0.012 millimeter) to about 5.0 mil (0.12 millimeter).
- Other alternative constructions for the pad wall include woven or nonwoven fibrous webs that have been constructed or treated to impart the desired level of liquid impermeability, or laminates formed of a woven or nonwoven fabric and thermoplastic film.
- the walls may optionally be composed of a vapor or gas permeable, microporous "breathable" material that is permeable to vapors or gas yet substantially impermeable to liquid.
- Breathability can be imparted to polymer films by, for example, using fillers in the film polymer formulation, extruding the filler/polymer formulation into a film and then stretching the film sufficiently to create voids around the filler particles, thereby making the film breathable.
- the more filler used and the higher the degree of stretching the greater the degree of breathability.
- kits are provided, containing the mammary gland pad of the invention.
- the pad of the invention is ideally suited for a kit for assisting in the removal of keratin plugs from the mammary gland.
- a kit comprises a container containing a mammary gland pad containing a detergent based solution for application to the mammary gland of a female.
- a kit of the invention contains one or more containers compartmentalized to hold a mammary gland pad and a mammary gland funnel system. The kit may further include instructions for use in obtaining mammary gland fluid from non-lactating females.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Pediatric Medicine (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU32303/00A AU3230300A (en) | 1999-02-12 | 2000-02-11 | Bifurcated method for preventing breast ductal cancer |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12021299P | 1999-02-12 | 1999-02-12 | |
US12041199P | 1999-02-12 | 1999-02-12 | |
US60/120,212 | 1999-02-12 | ||
US60/120,411 | 1999-02-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000047247A1 true WO2000047247A1 (fr) | 2000-08-17 |
Family
ID=26818161
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/003661 WO2000047247A1 (fr) | 1999-02-12 | 2000-02-11 | Technique d'utilisation detournee d'un dispositif dans un but de prevention du cancer canalaire du sein |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3230300A (fr) |
WO (1) | WO2000047247A1 (fr) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6328709B1 (en) | 1998-11-13 | 2001-12-11 | Pro Duct Health, Inc. | Devices and methods to identify ductal orifices during nipple aspiration |
WO2003066133A1 (fr) * | 2002-02-07 | 2003-08-14 | Medela Ag | Cloche de tire-lait |
EP1402056A2 (fr) * | 2001-05-30 | 2004-03-31 | Neomatrix, LLC. | Criblage diagnostic a l'aide d'un fluide intracanalaire non-invasif |
WO2007071093A1 (fr) * | 2005-12-22 | 2007-06-28 | Medela Holding Ag | Bonnet pour sein |
EP2130558A1 (fr) * | 2000-11-13 | 2009-12-09 | Ensisheim Partners LLC | Procédés et dispositifs pour la collecte, la manipulation et le traitement d'échantillons liquides de mamelles pour évaluer les maladies mammaires y compris le cancer |
WO2013066919A3 (fr) * | 2011-10-31 | 2013-07-25 | Zhang Henian | Systèmes et procédés de protection de la santé des seins ou des mamelles |
US8715225B2 (en) | 2010-06-07 | 2014-05-06 | Koninklijke Philips N.V. | Breast pump |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3822703A (en) * | 1973-02-13 | 1974-07-09 | P Davisson | Breast pump |
US5476492A (en) * | 1994-02-23 | 1995-12-19 | Unrug; Sophia | Body warmer for therapeutic purposes containing whole herb seed |
US5576329A (en) * | 1992-07-24 | 1996-11-19 | Hennessey; Richard K. | Method for treating tendon or joint inflammation with papaverine HCL |
US5664984A (en) * | 1996-05-08 | 1997-09-09 | Laughridge; Nancy E. | Brassiere having frontal moisture control |
US5776177A (en) * | 1992-12-21 | 1998-07-07 | Macwhinnie; Virginia | C-shaped heat pack for thermal treatment of breast |
US5810796A (en) * | 1996-01-10 | 1998-09-22 | Kao Corporation | Absorbent article |
US5885246A (en) * | 1995-02-16 | 1999-03-23 | Cannon Rubber Limited | Breast pump insert |
-
2000
- 2000-02-11 AU AU32303/00A patent/AU3230300A/en not_active Abandoned
- 2000-02-11 WO PCT/US2000/003661 patent/WO2000047247A1/fr active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3822703A (en) * | 1973-02-13 | 1974-07-09 | P Davisson | Breast pump |
US5576329A (en) * | 1992-07-24 | 1996-11-19 | Hennessey; Richard K. | Method for treating tendon or joint inflammation with papaverine HCL |
US5776177A (en) * | 1992-12-21 | 1998-07-07 | Macwhinnie; Virginia | C-shaped heat pack for thermal treatment of breast |
US5476492A (en) * | 1994-02-23 | 1995-12-19 | Unrug; Sophia | Body warmer for therapeutic purposes containing whole herb seed |
US5885246A (en) * | 1995-02-16 | 1999-03-23 | Cannon Rubber Limited | Breast pump insert |
US5810796A (en) * | 1996-01-10 | 1998-09-22 | Kao Corporation | Absorbent article |
US5664984A (en) * | 1996-05-08 | 1997-09-09 | Laughridge; Nancy E. | Brassiere having frontal moisture control |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6328709B1 (en) | 1998-11-13 | 2001-12-11 | Pro Duct Health, Inc. | Devices and methods to identify ductal orifices during nipple aspiration |
EP2130558A1 (fr) * | 2000-11-13 | 2009-12-09 | Ensisheim Partners LLC | Procédés et dispositifs pour la collecte, la manipulation et le traitement d'échantillons liquides de mamelles pour évaluer les maladies mammaires y compris le cancer |
EP1402056A2 (fr) * | 2001-05-30 | 2004-03-31 | Neomatrix, LLC. | Criblage diagnostic a l'aide d'un fluide intracanalaire non-invasif |
EP1402056A4 (fr) * | 2001-05-30 | 2009-04-08 | Neomatrix Llc | Criblage diagnostic a l'aide d'un fluide intracanalaire non-invasif |
WO2003066133A1 (fr) * | 2002-02-07 | 2003-08-14 | Medela Ag | Cloche de tire-lait |
WO2003066132A1 (fr) * | 2002-02-07 | 2003-08-14 | Medela Ag | Embout tire-lait |
US8597234B2 (en) | 2002-02-07 | 2013-12-03 | Medela Ag | Breast shield with sensor |
WO2007071093A1 (fr) * | 2005-12-22 | 2007-06-28 | Medela Holding Ag | Bonnet pour sein |
US8052634B2 (en) | 2005-12-22 | 2011-11-08 | Medela Holding Ag | Breast shield |
US8715225B2 (en) | 2010-06-07 | 2014-05-06 | Koninklijke Philips N.V. | Breast pump |
WO2013066919A3 (fr) * | 2011-10-31 | 2013-07-25 | Zhang Henian | Systèmes et procédés de protection de la santé des seins ou des mamelles |
Also Published As
Publication number | Publication date |
---|---|
AU3230300A (en) | 2000-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6832845B2 (ja) | 点滴を伴う動的陰圧療法 | |
US7108683B2 (en) | Wound therapy and tissue management system and method with fluid differentiation | |
JP5267962B2 (ja) | 負圧創傷療法において連続的排出を提供するシステム | |
CA1313804C (fr) | Tire-lait | |
US10016566B2 (en) | Systems and methods for maintaining breast or udder health | |
US9125770B2 (en) | Portable, adjustable disposable medical suction system and method of use | |
CN106176188B (zh) | 一种多功能中药熏蒸治疗仪 | |
WO2000047247A1 (fr) | Technique d'utilisation detournee d'un dispositif dans un but de prevention du cancer canalaire du sein | |
US20220296271A1 (en) | Micro-lipo needle devices and use thereof | |
JP7618180B2 (ja) | 液体用収集器 | |
US3281864A (en) | Portable bathing appliance for therapeutic use | |
CN204219476U (zh) | 一体式一次性多功能吸痰装置 | |
WO2022029509A1 (fr) | Collecteur pour liquides | |
CN104644333B (zh) | 一种用于贮存伤口渗出液的集液装置及负压治疗设备 | |
CN107296729A (zh) | 女性阴道按摩手套 | |
CN217067182U (zh) | 一种全密闭式吸脂罐 | |
CN206700383U (zh) | 一种妇科护理清洗器 | |
CN208319699U (zh) | 中药湿敷药袋 | |
CN211024392U (zh) | 一种树鼩自动吸奶器 | |
CN112220654A (zh) | 中医理疗仪主机 | |
WO1999021521A1 (fr) | Systeme de prelevements dans la cavite vaginale | |
CN212327086U (zh) | 一种消化内科用灌肠器 | |
CN220158720U (zh) | 一种中药熏蒸治疗器 | |
CN215230332U (zh) | 注射富血小板血浆来源性外泌体的给药设备 | |
CN201295421Y (zh) | 一次性灌肠包 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase |